chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Fluid intake reduced, Glomerular filtration rate decreased, Headache, Hyperkalaemia
Clinical narrative: Discharge Provider: DO Primary Care Provider at Discharge: MD  Admission Date: 8/3/2022 Discharge Date: 8/5/2022  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hyperkalemia [E87.5] Acute kidney injury [N17.9] Patient is a 55 y.o. female with PMH of HTN and DM who presented to the ED on 8/3 due to AKI and hyperkalemia on outpatient labs. Patient developed sinus pressure, HA, congestion, sore throat and dry cough on 8/1. She then took a home COVID test on 8/2 which was positive. She had a virtual visit with her PCP on 8/2 at which time labs were checked in anticipation of starting Paxlovid and showed Cr 1.89 compared to baseline 0.8. Patient endorses low fluid intake for the past month or so. Diet has been normal but had not eaten prior to arrival in the ED today.   In the ED, VS remained stable. Labs notable for Cr 2.02, K 6.1, eGFR 26. Mild tranaminitis. No imaging obtained. Patient was given IV fluids for her AKI as well as lasix, Ca gluconate and albuterol for her hyperkalemia.   Patient is essentially asymptomatic at discharge
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Hypertransaminasaemia, Laboratory test abnormal, Oropharyngeal pain, Paranasal sinus discomfort, Respiratory tract congestion
Clinical narrative: Discharge Provider: DO Primary Care Provider at Discharge: MD  Admission Date: 8/3/2022 Discharge Date: 8/5/2022  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hyperkalemia [E87.5] Acute kidney injury [N17.9] Patient is a 55 y.o. female with PMH of HTN and DM who presented to the ED on 8/3 due to AKI and hyperkalemia on outpatient labs. Patient developed sinus pressure, HA, congestion, sore throat and dry cough on 8/1. She then took a home COVID test on 8/2 which was positive. She had a virtual visit with her PCP on 8/2 at which time labs were checked in anticipation of starting Paxlovid and showed Cr 1.89 compared to baseline 0.8. Patient endorses low fluid intake for the past month or so. Diet has been normal but had not eaten prior to arrival in the ED today.   In the ED, VS remained stable. Labs notable for Cr 2.02, K 6.1, eGFR 26. Mild tranaminitis. No imaging obtained. Patient was given IV fluids for her AKI as well as lasix, Ca gluconate and albuterol for her hyperkalemia.   Patient is essentially asymptomatic at discharge
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Discharge Provider: DO Primary Care Provider at Discharge: MD  Admission Date: 8/3/2022 Discharge Date: 8/5/2022  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hyperkalemia [E87.5] Acute kidney injury [N17.9] Patient is a 55 y.o. female with PMH of HTN and DM who presented to the ED on 8/3 due to AKI and hyperkalemia on outpatient labs. Patient developed sinus pressure, HA, congestion, sore throat and dry cough on 8/1. She then took a home COVID test on 8/2 which was positive. She had a virtual visit with her PCP on 8/2 at which time labs were checked in anticipation of starting Paxlovid and showed Cr 1.89 compared to baseline 0.8. Patient endorses low fluid intake for the past month or so. Diet has been normal but had not eaten prior to arrival in the ED today.   In the ED, VS remained stable. Labs notable for Cr 2.02, K 6.1, eGFR 26. Mild tranaminitis. No imaging obtained. Patient was given IV fluids for her AKI as well as lasix, Ca gluconate and albuterol for her hyperkalemia.   Patient is essentially asymptomatic at discharge
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19
Clinical narrative: Admitted to the hospital with Covid-19
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Angiosarcoma, Asthenia, Blood culture, Blood glucose normal, COVID-19
Clinical narrative: Admission Date: 8/11/2022 Discharge Date: 8/13/2022  DISCHARGE DIAGNOSES 1. Acute delirium, multifactorial 2. COVID-19 3. Asymptomatic pyuria 4. Chronic combined systolic and diastolic heart failure 5. Angiosarcoma of the scalp, suspicion for metastasis  HOSPITAL COURSE: Patient is a 84 y.o. female with a past medical history significant for angiosarcoma of the scalp, HTN, essential tremor, ulcerative colitis s/p ileal resection with colostomy, aortic stenosis s/p TAVR, combined CHF, and hypothyroidism. She presented to the ED on 8/11/2022 after she reportedly fell at home and had been increasingly confused per family's report. She had no loss of consciousness nor did she suffer a head injury.   On arrival to the ED, patient was afebrile however COVID positive. Physical exam noted generalized weakness. Urinalysis was positive for WBC but symptomatic UTI was ruled out. Initial CBC, CMP, TSH, and glucose were unremarkable. CXR unremarkable for acute intrathoracic process. EKG unremarkable for acute myocardial ischemia. There was insignificant difference in initial and 2-hour troponin.  CT head unremarkable for acute bleed however it showed a 10 mm soft subcutaneous density in the right parotid. CT spine ruled out fractures. Patient was admitted to the general medical floor for further evaluation of weakness and cause of fall.   On the medical floor, EEG, blood cultures, and urine drug screen were obtained. Active seizures, infection, and substance abuse were ruled out as a cause of the patient's fall. With concern for acute CVA and negative initial head CT, MRI of the head was obtained. There was no evidence of infarction, hemorrhage, or intracranial metastasis, however mild chronic microvascular ischemic disease and mild cerebral atrophy were noted.    Patient's mental status returned back to baseline over course of admission. The medical team discussed with patient that many ominous causes of her fall were ruled out. Patient had classic signs and symptoms of acute delirium. This diagnosis was discussed with the patient and her family in detail. It was recommended by the primary medical team that the patient follow up with PCP and be referred to a neurologist for formal memory testing.    On 8/13/22, patient was medically and vitally stable for discharge home with family.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Cerebral atrophy, Cerebral small vessel ischaemic disease, Chest X-ray normal, Chronic left ventricular failure, Computerised tomogram head abnormal
Clinical narrative: Admission Date: 8/11/2022 Discharge Date: 8/13/2022  DISCHARGE DIAGNOSES 1. Acute delirium, multifactorial 2. COVID-19 3. Asymptomatic pyuria 4. Chronic combined systolic and diastolic heart failure 5. Angiosarcoma of the scalp, suspicion for metastasis  HOSPITAL COURSE: Patient is a 84 y.o. female with a past medical history significant for angiosarcoma of the scalp, HTN, essential tremor, ulcerative colitis s/p ileal resection with colostomy, aortic stenosis s/p TAVR, combined CHF, and hypothyroidism. She presented to the ED on 8/11/2022 after she reportedly fell at home and had been increasingly confused per family's report. She had no loss of consciousness nor did she suffer a head injury.   On arrival to the ED, patient was afebrile however COVID positive. Physical exam noted generalized weakness. Urinalysis was positive for WBC but symptomatic UTI was ruled out. Initial CBC, CMP, TSH, and glucose were unremarkable. CXR unremarkable for acute intrathoracic process. EKG unremarkable for acute myocardial ischemia. There was insignificant difference in initial and 2-hour troponin.  CT head unremarkable for acute bleed however it showed a 10 mm soft subcutaneous density in the right parotid. CT spine ruled out fractures. Patient was admitted to the general medical floor for further evaluation of weakness and cause of fall.   On the medical floor, EEG, blood cultures, and urine drug screen were obtained. Active seizures, infection, and substance abuse were ruled out as a cause of the patient's fall. With concern for acute CVA and negative initial head CT, MRI of the head was obtained. There was no evidence of infarction, hemorrhage, or intracranial metastasis, however mild chronic microvascular ischemic disease and mild cerebral atrophy were noted.    Patient's mental status returned back to baseline over course of admission. The medical team discussed with patient that many ominous causes of her fall were ruled out. Patient had classic signs and symptoms of acute delirium. This diagnosis was discussed with the patient and her family in detail. It was recommended by the primary medical team that the patient follow up with PCP and be referred to a neurologist for formal memory testing.    On 8/13/22, patient was medically and vitally stable for discharge home with family.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram spine, Condition aggravated, Confusional state, Delirium, Drug screen
Clinical narrative: Admission Date: 8/11/2022 Discharge Date: 8/13/2022  DISCHARGE DIAGNOSES 1. Acute delirium, multifactorial 2. COVID-19 3. Asymptomatic pyuria 4. Chronic combined systolic and diastolic heart failure 5. Angiosarcoma of the scalp, suspicion for metastasis  HOSPITAL COURSE: Patient is a 84 y.o. female with a past medical history significant for angiosarcoma of the scalp, HTN, essential tremor, ulcerative colitis s/p ileal resection with colostomy, aortic stenosis s/p TAVR, combined CHF, and hypothyroidism. She presented to the ED on 8/11/2022 after she reportedly fell at home and had been increasingly confused per family's report. She had no loss of consciousness nor did she suffer a head injury.   On arrival to the ED, patient was afebrile however COVID positive. Physical exam noted generalized weakness. Urinalysis was positive for WBC but symptomatic UTI was ruled out. Initial CBC, CMP, TSH, and glucose were unremarkable. CXR unremarkable for acute intrathoracic process. EKG unremarkable for acute myocardial ischemia. There was insignificant difference in initial and 2-hour troponin.  CT head unremarkable for acute bleed however it showed a 10 mm soft subcutaneous density in the right parotid. CT spine ruled out fractures. Patient was admitted to the general medical floor for further evaluation of weakness and cause of fall.   On the medical floor, EEG, blood cultures, and urine drug screen were obtained. Active seizures, infection, and substance abuse were ruled out as a cause of the patient's fall. With concern for acute CVA and negative initial head CT, MRI of the head was obtained. There was no evidence of infarction, hemorrhage, or intracranial metastasis, however mild chronic microvascular ischemic disease and mild cerebral atrophy were noted.    Patient's mental status returned back to baseline over course of admission. The medical team discussed with patient that many ominous causes of her fall were ruled out. Patient had classic signs and symptoms of acute delirium. This diagnosis was discussed with the patient and her family in detail. It was recommended by the primary medical team that the patient follow up with PCP and be referred to a neurologist for formal memory testing.    On 8/13/22, patient was medically and vitally stable for discharge home with family.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram normal, Electroencephalogram, Fall, Full blood count normal, Magnetic resonance imaging head abnormal
Clinical narrative: Admission Date: 8/11/2022 Discharge Date: 8/13/2022  DISCHARGE DIAGNOSES 1. Acute delirium, multifactorial 2. COVID-19 3. Asymptomatic pyuria 4. Chronic combined systolic and diastolic heart failure 5. Angiosarcoma of the scalp, suspicion for metastasis  HOSPITAL COURSE: Patient is a 84 y.o. female with a past medical history significant for angiosarcoma of the scalp, HTN, essential tremor, ulcerative colitis s/p ileal resection with colostomy, aortic stenosis s/p TAVR, combined CHF, and hypothyroidism. She presented to the ED on 8/11/2022 after she reportedly fell at home and had been increasingly confused per family's report. She had no loss of consciousness nor did she suffer a head injury.   On arrival to the ED, patient was afebrile however COVID positive. Physical exam noted generalized weakness. Urinalysis was positive for WBC but symptomatic UTI was ruled out. Initial CBC, CMP, TSH, and glucose were unremarkable. CXR unremarkable for acute intrathoracic process. EKG unremarkable for acute myocardial ischemia. There was insignificant difference in initial and 2-hour troponin.  CT head unremarkable for acute bleed however it showed a 10 mm soft subcutaneous density in the right parotid. CT spine ruled out fractures. Patient was admitted to the general medical floor for further evaluation of weakness and cause of fall.   On the medical floor, EEG, blood cultures, and urine drug screen were obtained. Active seizures, infection, and substance abuse were ruled out as a cause of the patient's fall. With concern for acute CVA and negative initial head CT, MRI of the head was obtained. There was no evidence of infarction, hemorrhage, or intracranial metastasis, however mild chronic microvascular ischemic disease and mild cerebral atrophy were noted.    Patient's mental status returned back to baseline over course of admission. The medical team discussed with patient that many ominous causes of her fall were ruled out. Patient had classic signs and symptoms of acute delirium. This diagnosis was discussed with the patient and her family in detail. It was recommended by the primary medical team that the patient follow up with PCP and be referred to a neurologist for formal memory testing.    On 8/13/22, patient was medically and vitally stable for discharge home with family.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Metabolic function test normal, Pyuria, SARS-CoV-2 test positive, Thyroid function test normal, Troponin
Clinical narrative: Admission Date: 8/11/2022 Discharge Date: 8/13/2022  DISCHARGE DIAGNOSES 1. Acute delirium, multifactorial 2. COVID-19 3. Asymptomatic pyuria 4. Chronic combined systolic and diastolic heart failure 5. Angiosarcoma of the scalp, suspicion for metastasis  HOSPITAL COURSE: Patient is a 84 y.o. female with a past medical history significant for angiosarcoma of the scalp, HTN, essential tremor, ulcerative colitis s/p ileal resection with colostomy, aortic stenosis s/p TAVR, combined CHF, and hypothyroidism. She presented to the ED on 8/11/2022 after she reportedly fell at home and had been increasingly confused per family's report. She had no loss of consciousness nor did she suffer a head injury.   On arrival to the ED, patient was afebrile however COVID positive. Physical exam noted generalized weakness. Urinalysis was positive for WBC but symptomatic UTI was ruled out. Initial CBC, CMP, TSH, and glucose were unremarkable. CXR unremarkable for acute intrathoracic process. EKG unremarkable for acute myocardial ischemia. There was insignificant difference in initial and 2-hour troponin.  CT head unremarkable for acute bleed however it showed a 10 mm soft subcutaneous density in the right parotid. CT spine ruled out fractures. Patient was admitted to the general medical floor for further evaluation of weakness and cause of fall.   On the medical floor, EEG, blood cultures, and urine drug screen were obtained. Active seizures, infection, and substance abuse were ruled out as a cause of the patient's fall. With concern for acute CVA and negative initial head CT, MRI of the head was obtained. There was no evidence of infarction, hemorrhage, or intracranial metastasis, however mild chronic microvascular ischemic disease and mild cerebral atrophy were noted.    Patient's mental status returned back to baseline over course of admission. The medical team discussed with patient that many ominous causes of her fall were ruled out. Patient had classic signs and symptoms of acute delirium. This diagnosis was discussed with the patient and her family in detail. It was recommended by the primary medical team that the patient follow up with PCP and be referred to a neurologist for formal memory testing.    On 8/13/22, patient was medically and vitally stable for discharge home with family.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Urine analysis abnormal, White blood cells urine positive
Clinical narrative: Admission Date: 8/11/2022 Discharge Date: 8/13/2022  DISCHARGE DIAGNOSES 1. Acute delirium, multifactorial 2. COVID-19 3. Asymptomatic pyuria 4. Chronic combined systolic and diastolic heart failure 5. Angiosarcoma of the scalp, suspicion for metastasis  HOSPITAL COURSE: Patient is a 84 y.o. female with a past medical history significant for angiosarcoma of the scalp, HTN, essential tremor, ulcerative colitis s/p ileal resection with colostomy, aortic stenosis s/p TAVR, combined CHF, and hypothyroidism. She presented to the ED on 8/11/2022 after she reportedly fell at home and had been increasingly confused per family's report. She had no loss of consciousness nor did she suffer a head injury.   On arrival to the ED, patient was afebrile however COVID positive. Physical exam noted generalized weakness. Urinalysis was positive for WBC but symptomatic UTI was ruled out. Initial CBC, CMP, TSH, and glucose were unremarkable. CXR unremarkable for acute intrathoracic process. EKG unremarkable for acute myocardial ischemia. There was insignificant difference in initial and 2-hour troponin.  CT head unremarkable for acute bleed however it showed a 10 mm soft subcutaneous density in the right parotid. CT spine ruled out fractures. Patient was admitted to the general medical floor for further evaluation of weakness and cause of fall.   On the medical floor, EEG, blood cultures, and urine drug screen were obtained. Active seizures, infection, and substance abuse were ruled out as a cause of the patient's fall. With concern for acute CVA and negative initial head CT, MRI of the head was obtained. There was no evidence of infarction, hemorrhage, or intracranial metastasis, however mild chronic microvascular ischemic disease and mild cerebral atrophy were noted.    Patient's mental status returned back to baseline over course of admission. The medical team discussed with patient that many ominous causes of her fall were ruled out. Patient had classic signs and symptoms of acute delirium. This diagnosis was discussed with the patient and her family in detail. It was recommended by the primary medical team that the patient follow up with PCP and be referred to a neurologist for formal memory testing.    On 8/13/22, patient was medically and vitally stable for discharge home with family.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: This was my second Moderna booster.  Originally given J&J vaccine, followed by two Moderna boosters.
Age: 16.0
Sex: F
Vaccine: HEPA, HPV9, MNQ, TDAP, VARCEL
Symptoms: Rash, Rash pruritic
Clinical narrative: Full body pruritic rash, treating with benadryl and sending pt to allergist for testing
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, Incorrect dose administered, No adverse event
Clinical narrative: BY ERROR, MODERNA  COVID 19  VACCINE BOOSTER DOSE #4 WAS ADMINISTERD IN FULL DOSE (0.5ml)  NO ADVERSE EVENT REPORTED BY PATIENT
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, COVID-19, Diarrhoea, Faeces soft, Mobility decreased
Clinical narrative: Discharge Provider: DO  Primary Care Physician at Discharge: MD  Admission Date: 8/10/2022  Discharge Date: 8/15/2022   Diarrhea, unspecified type [R19.7] Diarrhea due to COVID-19 [U07.1, A08.39] COVID-19 virus detected [U07.1]   HOSPITAL COURSE: Patient is a 13yo with PMHx DiGeorge, chronic lung disease, adrenal insufficiency, congenital heart disease, focal epilepsy, anxiety, hypothyroidism, GERD who presented to the ED on 8/10 with diarrhea and fever. He was subsequently diagnosed with COVID and admitted for further management.   Since admission, patient was received remdesivir since he was at high risk of complications secondary to COVID. Labs were ordered to ensure that he was handling the remdesivir okay. He was also switched to decadron in place of the hydrocortisone for his stress dosing for his adrenal insufficiency.    Patient was also at risk for thrombosis due to limited mobility, history of thrombus and because he was Covid positive. Heme/Onc was consulted and recommended Lovenox every 12h while admitted.    While admitted, his peripheral blood cultures grew staph hominis which was likely due to contamination from skin flora. On repeat blood cultures, there was no growth at the time of discharge. Infectious disease was consulted and will be following the results of the blood cultures after discharge to ensure that no antibiotics are needed.    Patient continued all home medications while admitted. He was also at his Yellow zone while hospitalized and received CPT BID, flovent, albuterol and his other home medications.   On day of discharge, patient remained medically stable. Diarrhea has improved to less frequent bowel movements which are somewhat firmer than before. Peripheral blood cultures will be followed by Infectious Disease after discharge and patient will be notified if they grow anything. Patient will resume all home medications and will not need a taper for his stress dosing of steroids.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive, Staphylococcus test positive
Clinical narrative: Discharge Provider: DO  Primary Care Physician at Discharge: MD  Admission Date: 8/10/2022  Discharge Date: 8/15/2022   Diarrhea, unspecified type [R19.7] Diarrhea due to COVID-19 [U07.1, A08.39] COVID-19 virus detected [U07.1]   HOSPITAL COURSE: Patient is a 13yo with PMHx DiGeorge, chronic lung disease, adrenal insufficiency, congenital heart disease, focal epilepsy, anxiety, hypothyroidism, GERD who presented to the ED on 8/10 with diarrhea and fever. He was subsequently diagnosed with COVID and admitted for further management.   Since admission, patient was received remdesivir since he was at high risk of complications secondary to COVID. Labs were ordered to ensure that he was handling the remdesivir okay. He was also switched to decadron in place of the hydrocortisone for his stress dosing for his adrenal insufficiency.    Patient was also at risk for thrombosis due to limited mobility, history of thrombus and because he was Covid positive. Heme/Onc was consulted and recommended Lovenox every 12h while admitted.    While admitted, his peripheral blood cultures grew staph hominis which was likely due to contamination from skin flora. On repeat blood cultures, there was no growth at the time of discharge. Infectious disease was consulted and will be following the results of the blood cultures after discharge to ensure that no antibiotics are needed.    Patient continued all home medications while admitted. He was also at his Yellow zone while hospitalized and received CPT BID, flovent, albuterol and his other home medications.   On day of discharge, patient remained medically stable. Diarrhea has improved to less frequent bowel movements which are somewhat firmer than before. Peripheral blood cultures will be followed by Infectious Disease after discharge and patient will be notified if they grow anything. Patient will resume all home medications and will not need a taper for his stress dosing of steroids.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Expired vaccine. No temperature excursion occurred. Moderna determined vial "maintained the activity necessary to protect against the SARS CoV-2 virus at the time of administration." No adverse event reported.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, Headache, Hypersomnia, Oropharyngeal pain
Clinical narrative: 05/16/2022 I had my vaccination. On 08/1/2022 we went to the doctors for my husband and stayed at a hotel. There was no air conditioning and it was in the 90's. The room was very hot and could not stay there that long. I think it allowed the germs to breath and believe where we got COVID-19. 08/02/2022 We went to my husbands doctor for his appointment. On Tuesday night, my husband was coughing and hacking. 08/03/2022 I woke up with a cough, labored breathing, headache and sore throat. I slept a lot. My husbands cough was getting worse with a temperature of 102. We tested and were COVID-19 Positive. We were prescribed Plaxovid. I am feeling much better and tested negative 08/16/2022.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: 05/16/2022 I had my vaccination. On 08/1/2022 we went to the doctors for my husband and stayed at a hotel. There was no air conditioning and it was in the 90's. The room was very hot and could not stay there that long. I think it allowed the germs to breath and believe where we got COVID-19. 08/02/2022 We went to my husbands doctor for his appointment. On Tuesday night, my husband was coughing and hacking. 08/03/2022 I woke up with a cough, labored breathing, headache and sore throat. I slept a lot. My husbands cough was getting worse with a temperature of 102. We tested and were COVID-19 Positive. We were prescribed Plaxovid. I am feeling much better and tested negative 08/16/2022.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: BY ERROR, MODERNA  COVID 19  VACCINE BOOSTER DOSE #4 WAS ADMINISTERD IN FULL DOSE (0.5ml)  NO ADVERSE EVENT REPORTED BY PATIENT
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: BY ERROR, MODERNA  COVID 19  VACCINE BOOSTER DOSE #4 WAS ADMINISTERD IN FULL DOSE (0.5ml)  NO ADVERSE EVENT REPORTED BY PATIENT
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Patient received a vaccine stored beyond 30 days recommended in the refrigerated state. Event reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. It was recommended repeating this dose. Patient sent a letter to inform them of the need to repeat the dose. We are working on a compliance improvement plan. Reinstated vaccination privileges.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Nasal congestion, Pyrexia, Rash
Clinical narrative: I was positive for COVID-19 on 06/26/2022. I had  nasal congestions;  mild fever few hours  and  after 2-3 days I had cough. I also had rash for 1/2 a day  on my skin.   On  06/27/2022 I did a telemedicine with  my doctor  he prescribed me  Azelastine  and PAXLOVID.  We discussed  about taking the medications  but since I had  mild symptoms  I didn't take it.  I  took Fluticasone for nasal congestions. I  also went to see  my specialist  because my nasal congestions got worst.  He gave me steroids   to reduce the congestions.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: I was positive for COVID-19 on 06/26/2022. I had  nasal congestions;  mild fever few hours  and  after 2-3 days I had cough. I also had rash for 1/2 a day  on my skin.   On  06/27/2022 I did a telemedicine with  my doctor  he prescribed me  Azelastine  and PAXLOVID.  We discussed  about taking the medications  but since I had  mild symptoms  I didn't take it.  I  took Fluticasone for nasal congestions. I  also went to see  my specialist  because my nasal congestions got worst.  He gave me steroids   to reduce the congestions.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: BY ERROR, MODERNA  COVID 19  VACCINE BOOSTER DOSE #4 WAS ADMINISTERD IN FULL DOSE (0.5ml)  NO ADVERSE EVENT REPORTED BY PATIENT
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Clinic consulted with Public Health and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Clinic is working with the Public Health on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, Incorrect dose administered
Clinical narrative: BY ERROR, MODERNA  COVID 19  VACCINE BOOSTER DOSE #4 WAS ADMINISTERD IN FULL DOSE (0.5ml)  NO ADVERSE EVENT REPORTED BY PATIENT
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Dizziness, SARS-CoV-2 test positive
Clinical narrative: Patient seen in the ED on 7/13 for weakness and dizziness. He had a positive COVID home test on 7/13 and COVID-19 PCR swab taken in the ED was also positive. His daughter was concerned about his generalized weakness and so patient was admitted for COVID-19 infection.  Patient admitted from 7/13-7/23. He is vaccinated against COVID-19. This meets criteria for vaccine breakthrough case review.
Age: 55.0
Sex: F
Vaccine: VARZOS
Symptoms: Discomfort, Fatigue, Feeling abnormal, Pruritus, Pyrexia
Clinical narrative: Patient received Shingrix vaccine.  2-3 days later she developed a fever and a rash on her upper right thigh ankle and on left great toe. Reports this started 2 days after her shingles shot and has gotten worse. Reports fever fatigue and feeling really run down.  Reports that it is mildly uncomfortable and consistent with a chicken pox dx her children had.  Reports that she did have chicken pox as a child. Chicken pox- Keep area clean and dry, Tylenol for fever >100.3, Benadryl may help with the itch. Get plenty of rest Soothing lotion and moisturizers - Calamine solution can be applied on the rashes. Colloidal oatmeal also gives relief from itching. Patient advised to stay away from children and pregnant people.  Advised if sx worsen she should contact the office for further eval and treatment.
Age: 55.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash
Clinical narrative: Patient received Shingrix vaccine.  2-3 days later she developed a fever and a rash on her upper right thigh ankle and on left great toe. Reports this started 2 days after her shingles shot and has gotten worse. Reports fever fatigue and feeling really run down.  Reports that it is mildly uncomfortable and consistent with a chicken pox dx her children had.  Reports that she did have chicken pox as a child. Chicken pox- Keep area clean and dry, Tylenol for fever >100.3, Benadryl may help with the itch. Get plenty of rest Soothing lotion and moisturizers - Calamine solution can be applied on the rashes. Colloidal oatmeal also gives relief from itching. Patient advised to stay away from children and pregnant people.  Advised if sx worsen she should contact the office for further eval and treatment.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: BY ERROR, MODERNA  COVID 19  VACCINE BOOSTER DOSE #4 WAS ADMINISTERD IN FULL DOSE (0.5ml)  NO ADVERSE EVENT REPORTED BY PATIENT
Age: 4.0
Sex: M
Vaccine: COVID19
Symptoms: Discomfort, Erythema, Oropharyngeal pain, Skin warm
Clinical narrative: Pediatric patient received 2nd moderna vaccine.  Patient complained throat was painful during observation time period.  based on assessment patient was warm and had redness to cheeks and bilateral arms. Patient able to verbalize areas of discomfort,
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19
Clinical narrative: Admitted to the hospital with COVID-19
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Heart rate increased, Pruritus, Swelling
Clinical narrative: All of this started at the end of the 30-minute wait period (for those of us with prior anaphylactic reactions...mine was due to a wasp), and I left and went back because my symptoms were disconcerting.  Had to get the parents to pick the car and me up after being monitored and dosed with Benadryl and almost hit with an epipen because my face was swelling (nose, lips, roof of my mouth to the point that my lips felt as if they would pop), BP and heartbeat elevated, and I itched from my shoulders up.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Incorrect dose administered
Clinical narrative: BY ERROR, MODERNA  COVID 19  VACCINE BOOSTER DOSE #4 WAS ADMINISTERD IN FULL DOSE (0.5ml)  NO ADVERSE EVENT REPORTED BY PATIENT
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Abdominal discomfort, Fatigue, Pain in extremity
Clinical narrative: Tired, sore arm, upset stomach
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: vaccine was expired, no temperature excursion occurred and moderna determined the vial "maintained the activity necessary to protect against the SARS CoV-2 virus at the time of administration".  Patient reported no adverse reactions.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdominal pain, Acute respiratory failure, COVID-19, COVID-19 pneumonia, Cough
Clinical narrative: Patient brought into the ED via EMS on 7/14 for shortness of breath, cough, and fatigue. Also reported nausea, vomiting, sore throat, headache, abdominal pain, and diarrhea. To note, patient drinks on a daily basis and has 4-5 drinks. COVID-19 PCR swab taken in the ED was positive. Ultimately patient admitted 7/14-7/16 and diagnosed with acute hypoxic respiratory failure, COVID-19 pneumonia, and presumed bacterial pneumonia. Patient is vaccinated against COVID-19. This meets criteria for vaccine breakthrough case review.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Diarrhoea, Dyspnoea, Fatigue, Headache, Nausea
Clinical narrative: Patient brought into the ED via EMS on 7/14 for shortness of breath, cough, and fatigue. Also reported nausea, vomiting, sore throat, headache, abdominal pain, and diarrhea. To note, patient drinks on a daily basis and has 4-5 drinks. COVID-19 PCR swab taken in the ED was positive. Ultimately patient admitted 7/14-7/16 and diagnosed with acute hypoxic respiratory failure, COVID-19 pneumonia, and presumed bacterial pneumonia. Patient is vaccinated against COVID-19. This meets criteria for vaccine breakthrough case review.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Oropharyngeal pain, Pneumonia bacterial, SARS-CoV-2 test positive, Vaccine breakthrough infection, Vomiting
Clinical narrative: Patient brought into the ED via EMS on 7/14 for shortness of breath, cough, and fatigue. Also reported nausea, vomiting, sore throat, headache, abdominal pain, and diarrhea. To note, patient drinks on a daily basis and has 4-5 drinks. COVID-19 PCR swab taken in the ED was positive. Ultimately patient admitted 7/14-7/16 and diagnosed with acute hypoxic respiratory failure, COVID-19 pneumonia, and presumed bacterial pneumonia. Patient is vaccinated against COVID-19. This meets criteria for vaccine breakthrough case review.
Age: 48.0
Sex: F
Vaccine: UNK, UNK, UNK
Symptoms: Polymenorrhoea
Clinical narrative: Frequent periods.  More than three times / every two months, sometimes 2 times a month (used to 29days or31days a cycle:  once a month).  It started when I got Moderna, so I changed to pfizer for 3rd shot since the symptom had not been improved. However, I still have same issues.  My doctor said, maybe I am going to have menopause soon, but I still feel it's not normal.
Age: 82.0
Sex: M
Vaccine: PNC15
Symptoms: Axillary pain, Erythema, Induration, Oedema peripheral
Clinical narrative: erythema, edema, tenderness with induration of tissue from left axilla extending distal to left medial epicondyle
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19
Clinical narrative: Admitted to the hospital with COVID-19
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Clinic consulted with Public Health and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Clinic is working with Public Health on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, Incorrect dose administered, No adverse event
Clinical narrative: BY ERROR, MODERNA  COVID 19  VACCINE BOOSTER DOSE #4 WAS ADMINISTERD IN FULL DOSE (0.5ml)  NO ADVERSE EVENT REPORTED BY PATIENT
Age: 14.0
Sex: M
Vaccine: MNQ
Symptoms: Wrong product administered
Clinical narrative: Patient received Menveo vaccine instead of Hepatitis A vaccine.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Moderna COVID-19 vaccine booster dose #4 administered in full dose (0.5mL) by error. No adverse event reported.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Consulted with the Dept of Public Health and Environment and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Healthcare is working on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: BY ERROR, MODERNA  COVID 19  VACCINE BOOSTER DOSE #4 WAS ADMINISTERD IN FULL DOSE (0.5ml)  NO ADVERSE EVENT REPORTED BY PATIENT
Age: 46.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a vaccine stored beyond 30 days recommended in the refrigerated state. Event reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. It was recommended repeating this dose. Patient sent a letter to inform them of the need to repeat the dose. We are working on a compliance improvement plan. Reinstated vaccination privileges.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: BY ERROR, MODERNA  COVID 19  VACCINE BOOSTER DOSE #4 WAS ADMINISTERD IN FULL DOSE (0.5ml)  NO ADVERSE EVENT REPORTED BY PATIENT
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Haemorrhoidal haemorrhage, Haemorrhoids thrombosed, Laboratory test normal
Clinical narrative: Thrombosed hemorrhoid that bled for four days before I contacted a doctor. Treated with Proctofoam and basic cleansing. Gradually cleared up over the course of 2 weeks.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chest pain, Dyspnoea, Electrocardiogram normal, Impaired work ability
Clinical narrative: The day of the vaccine I had chest tightness up to the 01/04/2022. On 01/05/2022, I had chest pain and extreme difficulty breathing. Used my inhaler about every 2 hours for relief. I went to a local urgent care center. They did an EKG and the results was normal. They prescribed a steroid and the inhaler. The steroid really helped me and I didn't have to use the inhaler as much. I was off from work for a whole week to recover.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Healthcare office consulted with the Dept of Public Health and Environment and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Healthcare is working with the DPHE on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: BY ERROR, MODERNA  COVID 19  VACCINE BOOSTER DOSE #4 WAS ADMINISTERD IN FULL DOSE (0.5ml)  NO ADVERSE EVENT REPORTED BY PATIENT
Age: 18.0
Sex: F
Vaccine: MNQ
Symptoms: Blood pressure decreased, Dizziness, Dysstasia, Fall, Hypotension
Clinical narrative: Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Mild, Systemic: Hypotension-Mild, Additional Details: Patient had a black out right after she received her Meningitis Vaccine.  Patient fell on the floor, but was responsive.  It took patient around 15 minutes to be able to stand up without feeling dizzy.  Patient's O2 saturation was above 99 percent the whole time.  But blood pressure was around 90/60.  Eventually patient's blood pressure went back up to 110/70 and patient was not having dizzy spells anymore.  Put in a note in her chart to call her to make sure she is doing better the next day.
Age: 18.0
Sex: F
Vaccine: MNQ
Symptoms: Immediate post-injection reaction, Loss of consciousness, Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Mild, Systemic: Hypotension-Mild, Additional Details: Patient had a black out right after she received her Meningitis Vaccine.  Patient fell on the floor, but was responsive.  It took patient around 15 minutes to be able to stand up without feeling dizzy.  Patient's O2 saturation was above 99 percent the whole time.  But blood pressure was around 90/60.  Eventually patient's blood pressure went back up to 110/70 and patient was not having dizzy spells anymore.  Put in a note in her chart to call her to make sure she is doing better the next day.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received a vaccine stored beyond 30 days recommended in the refrigerated state. Event reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. It was recommended repeating this dose. Patient sent a letter to inform them of the need to repeat the dose. We are working on a compliance improvement plan. Reinstated vaccination privileges.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: BY ERROR, MODERNA  COVID 19  VACCINE BOOSTER DOSE #4 WAS ADMINISTERD IN FULL DOSE (0.5ml)  NO ADVERSE EVENT REPORTED BY PATIENT
Age: 10.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test, Vaccine breakthrough infection
Clinical narrative: Breakthrough case COVID-19 after fully vaccinated with 2 doses.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Healthcare office consulted with the Dept of Public Health and Environment and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Healthcare is working with the DPHE on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: BY ERROR, MODERNA  COVID 19  VACCINE BOOSTER DOSE #4 WAS ADMINISTERD IN FULL DOSE (0.5ml)  NO ADVERSE EVENT REPORTED BY PATIENT
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Consulted with the Dept of Public Health and Environment and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Healthcare is working on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Acute respiratory failure, COVID-19, Cough, Headache, Interchange of vaccine products
Clinical narrative: Patient seen in the ED on 7/15 after testing positive for COVID at home. She reported coughing, headaches, and body aches. COVID-19 PCR swab also done in the ED and was positive. Patient did not feel safe being discharged home, so she was admitted from 7/15-7/18 and diagnosed with acute on chronic hypoxic respiratory failure due to COVID-19. She is vaccinated against COVID-19. This meets criteria for vaccine breakthrough case review.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Pain, Respiratory failure, SARS-CoV-2 test positive
Clinical narrative: Patient seen in the ED on 7/15 after testing positive for COVID at home. She reported coughing, headaches, and body aches. COVID-19 PCR swab also done in the ED and was positive. Patient did not feel safe being discharged home, so she was admitted from 7/15-7/18 and diagnosed with acute on chronic hypoxic respiratory failure due to COVID-19. She is vaccinated against COVID-19. This meets criteria for vaccine breakthrough case review.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Moderna COVID-19 vaccine booster dose #4 administered in full dose (0.5mL) by error. No adverse event reported.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: BY ERROR, MODERNA  COVID 19  VACCINE BOOSTER DOSE #4 WAS ADMINISTERD IN FULL DOSE (0.5ml)  NO ADVERSE EVENT REPORTED BY PATIENT
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Patient received a vaccine stored beyond 30 days recommended in the refrigerated state. Event reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. It was recommended repeating this dose. Patient sent a letter to inform them of the need to repeat the dose. We are working on a compliance improvement plan. Reinstated vaccination privileges.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram, Diplopia, Electrocardiogram, Headache, Magnetic resonance imaging
Clinical narrative: Diplopia (Double Vision) I had severe headache and neck pain on Wednesday, July 27 2022 around 3:00 pm which I expected. However, I started feeling unusual vision on July 28 and 29. On July 30th morning I started seeing distance diplopia. Dr. advised me t rush to Hospital. I was tested for EKG, CT Scan, and MRI on July 30 and 31 suspecting a stroke but I was cleared and sent home. On Wednesday August I was seen by Dr. He also confirmed diplopia. My headache persisted till Saturday August 13,2022 My diplopia continues till the time of this report.